drugset
drugset / Trial / NCT02900235

Mass Balance Study of MT-3995

NCT02900235 ↗

Phase 1 Completed 9 enrolled Tanabe Pharma Corporation
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to investigate the absorption, metabolism and excretion of MT-3995 in healthy subjects.

Timeline

Start
2016-08
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MT-3995 Small molecule — Oral

Indications

No indication recorded.